Guiding Questions
- B2.
What is the association between sedentary behaviour and health-related outcomes?
Is there a dose response association (total volume, frequency, duration, and intensity of interruptions)?
Does the association vary by type and domain of sedentary behaviour?
Does physical activity modify the effect of sedentary behaviour on mortality?
Inclusion Criteria
Population: Adults 18 years of age and older
Exposure: Greater volume, decreased frequency, duration or intensity of interruption of sedentary behaviour
Comparison: Lesser volume, increased frequency, duration or intensity of interruption of sedentary behaviour
View in own window
Outcomes | Importance |
---|
All-cause and cause-specific mortality | Critical |
Incidence of cardiovascular disease | Critical |
Incidence of cancer (site-specific) | Critical |
Incidence of Type 2 Diabetes | Critical |
Adiposity/Prevention of weight gain/Body composition | Critical |
Mental health outcomes (e.g. depressive symptoms, anxiety symptoms) | Important |
Cognitive outcomes (e.g. dementia, cognition) | Important |
Physical function (e.g., physical strength, fitness) | Important |
Musculoskeletal health (e.g., pain) | Important |
Sleep duration and quality | Important |
Health-related quality of life | Important |
Evidence identified
Twenty-two studies (published from 2017 to 2019) were initially identified that examined the association between sedentary behaviour and health-related outcomes among adults (1–22). Five review were subsequently excluded from further evaluation given the study design or exposures that were out-of-scope. presents the reviews that were excluded and their reason for exclusion.
Table B2.1Excluded Systematic Reviews, with Reasons for Exclusion
View in own window
Author, Year | Reason for Exclusion | Rationale |
---|
Al Tunaiji 2019 (2) | Exposure | Examines relationship between lack of MVPA and CVD incidence |
Baumeister 2019 (4) | Exposure | Examines relationship between PA and liver cancer |
Chastin 2017 (7) | Exposure | Examines relationship between light-intensity PA and health outcomes |
Friedenreich 2019 (11) | Design | Modelling study; underlying risk estimates not based on full systematic review methodology |
Fuzeki 2017 (12) | Design | Analysis of NHANES data only |
presents the ratings for each remaining review according to all the AMSTAR 2 main domains. In general, the included reviews were of moderate credibility. One review was rated as having high credibility, 9 were rated as having moderate credibility, 3 were rated as having low credibility, and the remaining 4 were rated as having critically low credibility. Given concerns regarding the comprehensiveness and the validity of the results presented in reviews rated as having critically low credibility, they were not incorporated into the final Evidence Profiles. A total of 13 reviews were included in the Evidence Profiles below.
lists the 17 reviews that were assessed by outcome. A de novo search for important outcomes, that were not included in the PAGAC report was not conducted due to resource constraints. Evidence Profiles for these outcomes, therefore, are not included in this report. Extracted data for each included review is presented in Appendix A.
Table B2.2Credibility Ratings (based on AMSTAR 2 (23))
View in own window
Author, Year | PICO1 | Apriori Methods2 | Study Design Selection3 | Lit Search Strategy4 | Study Selection5 | Data Extraction6 | Excluded Studies7 | Included Studies8 | RoB Assessment9 | Funding Sources10 | Statistical Methods11 | Impact of RoB12 | RoB Results13 | Heterogeneity14 | Publication Bias15 | COI16 | Overall Rating17 |
---|
Ahmad 2017 (1) | Y | PY | N | PY | Y | Y | Y | PY | PY | N | N/A | N/A | Y | Y | N/A | N | Moderate |
Bailey 2019 (3) | Y | PY | N | PY | Y | Y | PY | PY | PY | N | Y | Y | Y | Y | Y | Y | Moderate |
Berger 2019 (5) | Y | PY | N | PY | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | Y | Y | Moderate |
Chan 2019 (6) | Y | PY | N | PY | N | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Moderate |
del Pozo-Cruz 2018 (8) | Y | PY | N | PY | Y | N | PY | PY | Y | N | Y | Y | Y | Y | Y | Y | Moderate |
Ekelund 2018 (9) | Y | Y | N | PY | N | Y | PY | Y | PY | N | Y | Y | Y | Y | Y | Y | Moderate |
Ekelund 2019 (10) | Y | PY | N | PY | N | Y | PY | Y | Y | N | Y | N | N | N | Y | Y | Moderate |
Ku 2018 (13) | Y | N | Y | PY | N | Y | Y | Y | Y | N | Y | Y | N | Y | Y | Y | Moderate |
Ku 2019 (14) | Y | N | Y | PY | N | Y | Y | Y | Y | N | Y | Y | N | Y | Y | Y | Moderate |
Lee 2019 (15) | N | N | N | PY | N | N | PY | Y | Y | N | N | N | N | Y | Y | Y | Critically Low |
Ma 2018 (16) | N | N | N | PY | Y | Y | N | N | N | N | N | N | N | N | Y | N | Critically Low |
Mahmood 2017 (17) | Y | PY | N | PY | Y | Y | PY | Y | N | N | Y | N | N | Y | Y | Y | Low |
Mañas 2017 (18) | Y | N | N | PY | Y | N | PY | Y | N | N | N/A | N/A | N | N | N/A | Y | Critically Low |
Patterson 2018 (19) | Y | N | N | PY | N | Y | PY | Y | PY | N | Y | Y | N | Y | Y | Y | Low |
Shepard 2017 (20) | Y | N | N | N | N | N | N | Y | N | N | N/A | N/A | N | N | N/A | N | Critically Low |
Wang 2018 (21) | Y | Y | Y | Y | Y | Y | PY | Y | Y | N | Y | Y | Y | Y | Y | Y | High |
Xu 2019 (22) | Y | PY | N | N | N | N | N | Y | N | N | Y | N | N | Y | N | Y | Low |
Abbreviations: COI = conflict of interest; N = no; N/A = not applicable; PICO = population, intervention, comparator, outcome; PY = partial yes; RoB = risk of bias; Y = yes
- 1
Did the research questions and inclusion criteria for the review include the components of PICO?
- 2
Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol?
- 3
Did the review authors explain their selection of the study designs for inclusion in the review?
- 4
Did the review authors use a comprehensive literature search strategy?
- 5
Did the review authors perform study selection in duplicate?
- 6
Did the review authors perform data extraction in duplicate?
- 7
Did the review authors provide a list of excluded studies and justify the exclusions?
- 8
Did the review authors describe the included studies in adequate detail?
- 9
Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?
- 10
Did the review authors report on the sources of funding for the studies included in the review?
- 11
If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results?
- 12
If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?
- 13
Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review?
- 14
Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review?
- 15
If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?
- 16
Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?
- 17
Shea et al. 2017. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Table B2.3Systematic Reviews Assessed, by Author
View in own window
| Outcomes | | |
---|
Author, Year | ACM | Cause-specific mortality | CVD | Cancer | Diabetes | Adiposity | Mental health outcomes | Cognitive outcomes | Physical function | Musculoskeletal health | Sleep | HRQOL | Last Search Date | AMSTAR 2 |
---|
Ahmad 2017 (1) | | | ✕ | | ✕ | ✕ | | | | | | | Dec 2016 | Moderate |
---|
Bailey 2019 (3) | | | ✕ | | ✕ | | | | | | | | Feb 2019 | Moderate |
---|
Berger 2019 (5) | | Prostate | | Prostate | | | | | | | | | Jan 2019 | Moderate |
---|
Chan 2019 (6) | | | | Breast | | | | | | | | | Apr 2017 | Moderate |
---|
del Pozo-Cruz 2018 (8) | ✕ | | ✕ | | ✕ | ✕ | | | | | | | Dec 2016 | Moderate |
---|
Ekelund 2018a (9) | | CVD, Cancer | | | | | | | | | | | Oct 2015 | Moderate |
---|
Ekelund 2019 (10) | ✕ | | | | | | | | | | | | Jul 2018 | Moderate |
---|
Ku 2018 (13) | ✕ | | | | | | | | | | | | Jan 2018 | Moderate |
---|
Ku 2019 (14) | ✕ | | | | | | | | | | | | Mar 2019 | Moderate |
---|
Lee 2019 (15) | | | | Ovarian | | | | | | | | | Dec 2017 | Critically Low |
---|
Ma 2018 (16) | | | | Colorectal | | | | | | | | | Feb 2017 | Critically Low |
---|
Mahmood 2017 (17) | | | | Colorectal | | | | | | | | | Dec 2015 | Low |
---|
Mañas 2017 (18) | ✕b | | | | | | | | | | | | Oct 2016 | Critically Low |
---|
Patterson 2018 (19) | ✕ | CVD, Cancer | | | ✕ | | | | | | | | Sep 2016 | Low |
---|
Shepard 2017 (20) | | | | Bladder | | | | | | | | | Jun 2016 | Critically Low |
---|
Wang 2018 (21) | | | | Colorectal | | | | | | | | | Sep 2018 | High |
---|
Xu 2019c (22) | ✕ | | | | | | | | | | | | May 2018 | Low |
---|
- a
Secondary data analysis of 2016 review
- b
Not included for this outcome given better quality reviews reporting this outcome
- c
Individual participant data meta-analysis
Appendix A. Data Extractions of Included Evidence (in alphabetical order by author)
Download PDF (103K)
References
- 1.
Ahmad
S, Shanmugasegaram
S, Walker
KL, Prince
SA. Examining sedentary time as a risk factor for cardiometabolic diseases and their markers in South Asian adults: a systematic review. International journal of public health. 2017/03/17 ed2017. p. 503–15. [
PubMed: 28299392]
- 2.
Al Tunaiji
H, Davis
JC, Mansournia
MA, Khan
KM. Population attributable fraction of leading non-communicable cardiovascular diseases due to leisure-time physical inactivity: A systematic review. BMJ open sport & exercise medicine. 2019/06/14 ed2019. p. e000512. [
PMC free article: PMC6539142] [
PubMed: 31191969]
- 3.
Bailey
DP, Hewson
DJ, Champion
RB, Sayegh
SM. Sitting Time and Risk of Cardiovascular Disease and Diabetes: A Systematic Review and Meta-Analysis. American journal of preventive medicine. 2019;57(3):408–16. [
PubMed: 31377090]
- 4.
Baumeister
SE, Leitzmann
MF, Linseisen
J, Schlesinger
S. Physical Activity and the Risk of Liver Cancer: A Systematic Review and Meta-Analysis of Prospective Studies and a Bias Analysis. Journal of the National Cancer Institute. 2019;111(11):1142–51. [
PMC free article: PMC6855940] [
PubMed: 31168582]
- 5.
Berger
FF, Leitzmann
MF, Hillreiner
A, Sedlmeier
AM, Prokopidi-Danisch
ME, Burger
M, et al. Sedentary Behavior and Prostate Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Cancer prevention research (Philadelphia, Pa). 2019;12(10):675–88. [
PubMed: 31362941]
- 6.
Chan
DSM, Abar
L, Cariolou
M, Nanu
N, Greenwood
DC, Bandera
EV, et al. World Cancer Research Fund International: Continuous Update Project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer causes & control : CCC. 2019;30(11):1183–200. [
PubMed: 31471762]
- 7.
Chastin
SFM, De Craemer
M, De Cocker
K, Powell
L, Van Cauwenberg
J, Dall
P, et al. How does light-intensity physical activity associate with adult cardiometabolic health and mortality? Systematic review with meta-analysis of experimental and observational studies. British journal of sports medicine. 2019;53(6):370–6. [
PMC free article: PMC6579499] [
PubMed: 29695511]
- 8.
del Pozo-Cruz
J, Garcia-Hermoso
A, Alfonso-Rosa
RM, Alvarez-Barbosa
F, Owen
N, Chastin
S, et al. Replacing sedentary time: Meta-analysis of objective-assessment studies. American journal of preventive medicine. 2018;55(3):395–402. [
PubMed: 30122216]
- 9.
Ekelund
U, Brown
WJ, Steene-Johannessen
J, Fagerland
MW, Owen
N, Powell
KE, et al. Do the associations of sedentary behaviour with cardiovascular disease mortality and cancer mortality differ by physical activity level? A systematic review and harmonised meta-analysis of data from 850 060 participants. British journal of sports medicine. 2018;53(14):886–94. [
PubMed: 29991570]
- 10.
Ekelund
U, Tarp
J, Steene-Johannessen
J, Hansen
BH, Jefferis
B, Fagerland
MW, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: Systematic review and harmonised meta-analysis. BMJ. 2019;366:l4570. [
PMC free article: PMC6699591] [
PubMed: 31434697]
- 11.
Friedenreich
CM, Pader
J, Barberio
AM, Ruan
Y, Poirier
AE, Grevers
X, et al. Estimates of the current and future burden of cancer attributable to sedentary behavior in Canada. Preventive medicine. 2019;122:73–80. [
PubMed: 31078175]
- 12.
Fuzeki
E, Engeroff
T, Banzer
W. Health benefits of light-intensity physical activity: A systematic review of accelerometer data of the National Health and Nutrition Examination Survey (NHANES). Sports medicine (Auckland, NZ). 2017;47(9):1769–93. [
PubMed: 28393328]
- 13.
Ku
PW, Steptoe
A, Liao
Y, Hsueh
MC, Chen
LJ. A cut-off of daily sedentary time and all-cause mortality in adults: a meta-regression analysis involving more than 1 million participants. BMC medicine. 2018;16(1):74. [
PMC free article: PMC5998593] [
PubMed: 29793552]
- 14.
Ku
PW, Steptoe
A, Liao
Y, Hsueh
MC, Chen
LJ. A Threshold of Objectively-Assessed Daily Sedentary Time for All-Cause Mortality in Older Adults: A Meta-Regression of Prospective Cohort Studies. Journal of clinical medicine. 2019;8(4). [
PMC free article: PMC6517908] [
PubMed: 31027301]
- 15.
Lee
J. Physical activity, sitting time, and the risk of ovarian cancer: A brief research report employing a meta-analysis of existing. Health care for women international. 2019;40(4):433–58. [
PubMed: 30358498]
- 16.
Ma
P, Yao
Y, Sun
W, Dai
S, Zhou
C. Daily sedentary time and its association with risk for colorectal cancer in adults: A dose-response meta-analysis of prospective cohort studies. Medicine. 2017;96(22):e7049. [
PMC free article: PMC5459729] [
PubMed: 28562564]
- 17.
Mahmood
S, MacInnis
RJ, English
DR, Karahalios
A, Lynch
BM. Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysis. International journal of epidemiology. 2017;46(6):1797–813. [
PubMed: 29025130]
- 18.
Manas
A, Del Pozo-Cruz
B, Garcia-Garcia
FJ, Guadalupe-Grau
A, Ara
I. Role of objectively measured sedentary behaviour in physical performance, frailty and mortality among older adults: A short systematic review. European journal of sport science. 2017;17(7):940–53. [
PubMed: 28532299]
- 19.
Patterson
R, McNamara
E, Tainio
M, de Sa
TH, Smith
AD, Sharp
SJ, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. European journal of epidemiology. 2018;33(9):811–29. [
PMC free article: PMC6133005] [
PubMed: 29589226]
- 20.
Shephard
RJ. Physical activity in the prevention and management of bladder cancer. The Journal of sports medicine and physical fitness. 2017;57(10):1359–66. [
PubMed: 28116879]
- 21.
Wang
J, Huang
L, Gao
Y, Wang
Y, Chen
S, Huang
J, et al. Physically active individuals have a 23% lower risk of any colorectal neoplasia and a 27% lower risk of advanced colorectal neoplasia than their non-active counterparts: systematic review and meta-analysis of observational studies. British journal of sports medicine. 2019. [
PubMed: 31296585]
- 22.
Xu
C, Furuya-Kanamori
L, Liu
Y, Faerch
K, Aadahl
M, R AS, et al. Sedentary Behavior, Physical Activity, and All-Cause Mortality: Dose-Response and Intensity Weighted Time-Use Meta-analysis. Journal of the American Medical Directors Association. 2019;20(10):1206–12.e3. [
PubMed: 31272857]
- 23.
Shea
BJ, Reeves
BC, Wells
G, Thuku
M, Hamel
C, Moran
J, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. [
PMC free article: PMC5833365] [
PubMed: 28935701]
- 24.
2018 Physical Activity Guidelines Advisory Committee. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC. 2018. p. 1–779.